Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients Read More > January 13, 2020
Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses Read More > December 19, 2019
4-MeO-PCP and 3-MeO-PCMo, new dissociative drugs, produce rewarding and reinforcing effects through activation of mesolimbic dopamine pathway and alteration of accumbal CREB, deltaFosB, and BDNF levels Read More > December 11, 2019
Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment Read More > December 10, 2019
The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression Read More > September 11, 2019
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders Read More > August 27, 2019
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model Read More > May 15, 2019
Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action Read More > March 22, 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety Read More > March 1, 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder Read More > February 21, 2019
